PHI with Peripheral artery disease
How does this condition affect your private health insurance?
Peripheral Arterial Occlusive Disease (PAVK), also known as Peripheral Artery Disease (PAD), is a common circulatory condition where narrowed arteries reduce blood flow to the limbs, most commonly the legs. This narrowing is typically caused by atherosclerosis, the build-up of fatty plaques in the arteries. Symptoms often include intermittent claudication (leg pain during exercise that subsides with rest), numbness, coldness, or non-healing sores in the affected limb. Severe PAVK can lead to critical limb ischemia, causing pain at rest and tissue loss, potentially requiring amputation. It's a significant indicator of widespread atherosclerosis, increasing the risk of heart attack and stroke. Management involves lifestyle changes, medication, and sometimes revascularization procedures.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several weeks to months (onset of symptoms leading to diagnosis)
Duration of Illness (Lifetime)
Chronic, progressive disease requiring lifelong management
Cost of Treatment (Initial)
Moderate to High (diagnostic tests, medications, potential initial revascularization procedure)
Cost of Treatment (Lifetime)
High (ongoing medications, regular follow-ups, potential repeat procedures, wound care, rehabilitation)
Mortality Rate
Significantly increases risk of cardiovascular mortality (heart attack, stroke); direct mortality from critical limb ischemia complications can also occur.
Risk of Secondary Damages
High (e.g., critical limb ischemia, non-healing ulcers, limb amputation, heart attack, stroke, kidney failure)
Probability of Full Recovery
Low (the underlying atherosclerosis is a chronic condition; symptoms can be managed and progression slowed but complete reversal is rare)
Underlying Disease Risk
High (common comorbidities include hypertension, diabetes mellitus, dyslipidemia, coronary artery disease, cerebrovascular disease)